| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/08/2008 | CA2203901C Polymeric wound healing accelerators |
| 01/08/2008 | CA2181841C Transport vehicles for macromolecules |
| 01/08/2008 | CA2121716C Method and medical agent for diagnosis of arthritis |
| 01/08/2008 | CA2104111C Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 01/06/2008 | CA2686927A1 Superporous hydrogels for heavy-duty applications |
| 01/03/2008 | WO2008001872A1 Ophthalmic composition containing alginic acid or salt thereof |
| 01/03/2008 | WO2008001849A1 Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 01/03/2008 | WO2008001672A1 Tablet composition containing chinese herb extract |
| 01/03/2008 | WO2008001599A1 Process for production of hollow-fiber-like organic nanotube |
| 01/03/2008 | WO2008001591A1 Nucleus particle for layering and method for producing the same |
| 01/03/2008 | WO2008001240A2 Transdermal delivery of oleocanthal for relief of inflammation |
| 01/03/2008 | WO2008001200A2 Transdermal composition having enhanced color stability |
| 01/03/2008 | WO2008000710A1 Formulations comprising a vitamin and the use thereof to make fortified feed and personal care formulations |
| 01/03/2008 | WO2008000534A1 Solubilisate formulations |
| 01/03/2008 | WO2008000517A2 Conjugates for innate immunotherapy of cancer |
| 01/03/2008 | WO2008000429A2 Polymers with antimicrobial activity containing quaternary ammonium groups |
| 01/03/2008 | WO2008000166A1 Granule and preparation method thereof |
| 01/03/2008 | WO2008000040A1 A stabilised composition comprising ace inhibitors |
| 01/03/2008 | WO2007123984A3 Pre-mixed, ready-to-use pharmaceutical compositions |
| 01/03/2008 | WO2007102052A3 Foam containing unique oil globules |
| 01/03/2008 | WO2007084541A3 Central administration of stable formulations of therapeutic agents for cns conditions |
| 01/03/2008 | WO2007067681A3 Immunostimulatory compositions and methods |
| 01/03/2008 | WO2001028590A3 PHARMACEUTICAL COMPOSITIONS CONTAINING N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER |
| 01/03/2008 | US20080004398 Bioactive Biomaterials for Controlled Delivery of Active Principles |
| 01/03/2008 | US20080004340 Cationic Cassia Derivatives and Applications Therefor |
| 01/03/2008 | US20080004221 High Molecular Weight Derivatives of Vitamin K-Dependent Polypeptides |
| 01/03/2008 | US20080004211 Inhibitors of Amyloid Fibril Formation and Uses Thereof |
| 01/03/2008 | US20080003651 producing cyclotetrasaccharide of glucose units; use as filler, stabilizer, sweetener among other things in drugs, cosmetics and foods |
| 01/03/2008 | US20080003309 Yoghurt Formulation Cosmetic Composition |
| 01/03/2008 | US20080003298 Emulsifying a reverse micelle solution with with a solution of condensation agent (H2O), catalyst, polar solvent and active material , to generate droplets containing active material; and adding a silica-, alumina-, titanium dioxide-, iron oxide-, and/or zirconium dioxide-based gel precursor solution |
| 01/03/2008 | US20080003296 Amorphous Cyclodextrin Compositions |
| 01/03/2008 | US20080003295 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 01/03/2008 | US20080003294 Methods for pulmonary delivery of interleukin-2 |
| 01/03/2008 | US20080003293 Use of Buckysome or Carbon Nanotube for Drug Delivery |
| 01/03/2008 | US20080003289 Method for the Production of Effervescent Granules in a Vacuum |
| 01/03/2008 | US20080003288 Responsive microgel and methods related thereto |
| 01/03/2008 | US20080003277 Agent for improving tissue penetration |
| 01/03/2008 | US20080003267 Pharmaceutical Composition |
| 01/03/2008 | US20080003266 Composition Comprising Statins |
| 01/03/2008 | US20080003265 Protein and fiber containing dietary supplement |
| 01/03/2008 | US20080003264 Confectionary product for expressing and controlling the emotions of individuals |
| 01/03/2008 | US20080003263 Anti-Gluten Egg Yolk Antibodies for the Treatment of Celiac Disease |
| 01/03/2008 | US20080003255 Method for augmenting, reducing, and repairing bone with thermoplastic materials |
| 01/03/2008 | US20080003253 Block copolymers including a methoxyethyl methacrylate midblock |
| 01/03/2008 | DE10245212B4 Verwendung säurehaltiger Mittel zur Desensibilisierung von Zähnen Using acidic agent for desensitization of teeth |
| 01/03/2008 | DE102006030164A1 Inhalative Pulver Inhalation powder |
| 01/03/2008 | DE102006029500A1 Verwendung einer antimikrobiellen härtenden Alginatmasse zur topischen Behandlung von Wunden und Entzündungen in der Human-, Zahn- und Veterinärmedizin Use of an antimicrobial curing alginate for the topical treatment of wounds and inflammation in human medicine, dentistry and veterinary medicine |
| 01/03/2008 | CA2659206A1 Formulations comprising a vitamin and the use thereof to make fortified feed and personal care formulations |
| 01/03/2008 | CA2657084A1 Pellet formulation comprising colloidal silicon dioxide |
| 01/03/2008 | CA2656604A1 Injectable formulation of antibiotic and solution for intravenous administration thereof |
| 01/03/2008 | CA2654506A1 Antimicrobial articles comprising quaternary ammonium capped polymers |
| 01/03/2008 | CA2654414A1 Granule and preparation method thereof |
| 01/03/2008 | CA2654264A1 Inhalant powder containing phenylalanine |
| 01/03/2008 | CA2653382A1 A stabilised composition comprising ace inhibitors |
| 01/02/2008 | EP1873240A1 hTERT GENE EXPRESSION REGULATORY GENE |
| 01/02/2008 | EP1873204A1 Polymeric pharmaceutical agent for treatment of cancer and process for production of the same |
| 01/02/2008 | EP1873196A1 Porous cellulose aggregate and molding composition thereof |
| 01/02/2008 | EP1873167A2 Method of obtaining hydrogels of cyclodextrins with glycidyl ethers, compositions thus obtained and applications thereof |
| 01/02/2008 | EP1872799A1 External preparation, method of applying external preparation, iontophoresis device and transdermal patch |
| 01/02/2008 | EP1872798A1 Intestinal absorptive anti-tumor agent |
| 01/02/2008 | EP1872796A1 Transdermal preparation for external use containing nonsteroidal antiinflammatory/analgesic agent |
| 01/02/2008 | EP1872788A1 External agent for treating wound |
| 01/02/2008 | EP1872786A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 01/02/2008 | EP1872785A1 pharmaceutical composition comprising condensed indole compound |
| 01/02/2008 | EP1872784A1 Medicinal preparation for percutaneous absorption |
| 01/02/2008 | EP1872776A2 Mousse composition |
| 01/02/2008 | EP1872774A1 A pharmaceutical composition adapted for oral transmucosal administration comprising sex hormone and its use |
| 01/02/2008 | EP1872135A2 The use of antibody-surrogate antigen systems for detection of analytes |
| 01/02/2008 | EP1871878A2 Highly porous polymeric materials comprising biologically active molecules via covalent grafting |
| 01/02/2008 | EP1871803A1 Stabilized anti-hepatitis b (hbv) antibody formulations |
| 01/02/2008 | EP1871424A2 Immunoliposome composition for targeting to a her2 cell receptor |
| 01/02/2008 | EP1871423A2 Nanoparticle/active ingredient conjugate |
| 01/02/2008 | EP1871422A2 Uses of rhcc peptide in drug delivery, renal filtering, chemical catalysis and production of nanoparticles |
| 01/02/2008 | EP1871396A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor |
| 01/02/2008 | EP1871387A1 Intravenous formulations of pyridoxal 5'-phosphate and method of preparation |
| 01/02/2008 | EP1871384A2 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
| 01/02/2008 | EP1871348A2 Sustained release pharmaceutical compositions |
| 01/02/2008 | EP1776143B1 Bifunctional derivatives of polyethylene glycol, their preparation and use |
| 01/02/2008 | EP1695094A4 Disintegratable films for diagnostic devices |
| 01/02/2008 | EP1550675B1 Phospholipid derivative |
| 01/02/2008 | EP1521573B1 Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 01/02/2008 | EP1499346B1 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 01/02/2008 | EP1471898B1 Lutein/zeaxanthin for glare protection |
| 01/02/2008 | EP1465663B1 Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent |
| 01/02/2008 | EP1465643B1 Methods and compositions for oxygen transport with high oxygen affinity |
| 01/02/2008 | EP1432802B1 Pegylated and diglycosylated erythropoietin |
| 01/02/2008 | EP1381376B1 Water-absorbent polymers and their use |
| 01/02/2008 | EP1331928B1 Particle formation methods and their products |
| 01/02/2008 | EP1317476B1 Reagents for cell selection and methods of use |
| 01/02/2008 | EP1278868B1 Mutated form of arginine deiminase |
| 01/02/2008 | EP1272161B1 Lipid-based drug delivery systems against parasitic infections |
| 01/02/2008 | EP1154757B1 Fast dispersing dosage forms free of gelatin |
| 01/02/2008 | EP1128847B1 Antibody-serum protein hybrids |
| 01/02/2008 | EP1128827B1 Multilayer tablet comprising rosiglitazone |
| 01/02/2008 | EP1121116B1 Sustained release pharmaceutical composition of fluvastatin |
| 01/02/2008 | EP1028978B1 Methods of preparing glycosylated antibodies and antibody fragments having reactive ketone groups |
| 01/02/2008 | CN101098854A Bivalent linkers and conjugates thereof |
| 01/02/2008 | CN101098714A Compositions comprising azelastine and methods of use thereof |
| 01/02/2008 | CN101098684A Preventive/therapeutic composition for free radical disease |
| 01/02/2008 | CN101098678A Dpi formulation containing sulfoalkyl ether cyclodextrin |